Hareesh Nair | Drug Discovery and Development | Outstanding Scientist Award

Dr. Hareesh Nair | Drug Discovery and Development | Outstanding Scientist Award

Texas Tech University Health Science Center | United States

Dr. Hareesh B. Nair, Ph.D., is a distinguished biochemist and translational scientist whose career spans academia, biotechnology innovation, and advanced research leadership. He completed his academic training in life sciences and biochemistry in India, followed by specialized research fellowships in oxidative lipidomics and hormonal carcinogenesis at leading U.S. institutions. These early experiences laid the foundation for his lifelong commitment to understanding disease mechanisms and developing targeted therapeutic solutions.Dr. Nair’s professional journey reflects a rare blend of deep scientific expertise and strategic research leadership. Over the course of his career, he has held progressive roles ranging from instructor and assistant professor to senior scientist, director, and senior director of translational research and external innovation. His contributions at the University of Texas Health Science Center at San Antonio and the Texas Biomedical Research Institute significantly advanced the fields of breast cancer biology, hormonal carcinogenesis, melanoma signaling pathways, endometriosis, uterine fibroids, and targeted drug delivery. His work also includes pioneering estrogen-dependent cancer research, mechanistic studies on aromatase pathways, development of innovative cancer detection strategies, and creation of non-human primate models for reproductive disorders.At Evestra, Inc., Dr. Nair led multidisciplinary teams driving the translational development of oncology and women’s health therapeutics. He spearheaded multiple preclinical programs, established strategic collaborations, guided biomarker discovery, contributed to regulatory submissions, and supported business development through scientific due diligence. His leadership also resulted in the advancement of first-in-class and best-in-class therapeutic candidates, expansion of oncology pipelines, and successful acquisition of non-dilutive federal funding. His contributions include numerous publications, patents, and project management of large-scale contraceptive development initiatives supported by major global health foundations.In his current academic role at Texas Tech University Health Sciences Center El Paso, Dr. Nair is establishing a cutting-edge research laboratory at the chemistry–biology interface. His group focuses on identifying novel drug targets, decoding disease mechanisms, and transforming molecular insights into preclinical therapeutic strategies for cancers and other complex diseases. He remains deeply engaged in collaborative clinical and translational research, particularly in gynecologic oncology, triple-negative breast cancer, ovarian cancer, and endometrial cancer. His expertise also extends to long-acting contraceptive technologies, anti-HIV formulations, and experimental therapeutics for endometriosis and uterine fibroids.Beyond research, Dr. Nair has served extensively as a scientific review officer, facilitating numerous peer-review panels for federal biomedical research programs. His work has been recognized through multiple competitive honors, travel awards, and scientific achievement distinctions. With a strong commitment to innovation, mentorship, and multidisciplinary collaboration, Dr. Hareesh B. Nair continues to shape the future of translational medicine through impactful research, strategic leadership, and unwavering dedication to improving patient health outcomes.

Profile: Orcid

Featured Publications

Aller, E. J., Nair, H. B., Vadlamudi, R. K., & Viswanadhapalli, S. (2025). Significance of midkine signaling in women’s cancers: novel biomarker and therapeutic target. International Journal of Molecular Sciences, 26(10), 4809.

Blankenship, L., Pratap, U. P., Yang, X., Liu, Z., Altwegg, K. A., Santhamma, B., … Lai, Z. (2022). Inhibition of LIFR blocks adiposity‑driven endometrioid endometrial cancer growth. Cancers, 14(21), 5400.

Nair, H. B., Ford, A., Dick, E. J., Jr., Hill, R. H., Jr., & VandeBerg, J. L. (2014). Modeling sunscreen‑mediated melanoma prevention in the laboratory opossum (Monodelphis domestica). Pigment Cell & Melanoma Research, 27(5), 822‑830.

Nickisch, K., Nair, H. B., Kesavaram, N., Das, B., Garfield, R., Shi, S. Q., … Edwards, D. P. (2013). Synthesis and antiprogestational properties of novel 17‑fluorinated steroids. Steroids, 78(9), 895‑902.

Bhaskaran, S., Dileep, K. V., Deepa, S. S., Sadasivan, C., Klausner, M., Krishnegowda, N. K., … Nair, H. B. (2013). Gossypin as a novel selective dual inhibitor of V‑RAF murine sarcoma viral oncogene homolog B1 and cyclin‑dependent kinase 4 for melanoma. Molecular Cancer Therapeutics, 12(4), 567‑576.

Budrys, N. M., Nair, H. B., Liu, Y. G., Kirma, N. B., Binkley, P. A., Kumar, S., … Tekmal, R. R. (2012). Increased expression of macrophage colony‑stimulating factor and its receptor in patients with endometriosis. Fertility and Sterility, 97(5), 1159‑1165.e1.

Basharat Ali | Drug Discovery and Development | Best Researcher Award

Assist. Prof. Dr. Basharat Ali | Drug Discovery and Development | Pakistan

University of Baltistan | Pakistan

Assist. Prof. Dr. Basharat Ali is a distinguished researcher and academician specializing in medicinal chemistry, heterocyclic synthesis, and polymer science with extensive expertise in designing and synthesizing biologically active compounds. Currently serving as an Assistant Professor in the Department of Chemistry at the University of Baltistan, Skardu, Pakistan, he has a diverse academic and research background, including postdoctoral research at the College of Pharmaceutical Science, Soochow University, China, where he contributed to the development of chemiluminescent dioxetane probes for disease diagnosis, fluorescent probes for hydrogen sulfide detection, and anthraquinone derivatives as anti-infective agents. He has also worked as a research assistant at Zhejiang University, China, focusing on mechanistic studies of olefin polymerization using α-Diimine nickel(II) catalysts, and at the HEJ Research Institute of Chemistry, University of Karachi, where he specialized in synthetic organic chemistry and bioactive heterocycles.Dr. Basharat Ali’s research interests include the synthesis, structural modification, and biological evaluation of medicinally important synthetic derivatives, probe design for environmental and biomedical applications, multicomponent reactions, polymer synthesis, and catalytic system development. He has supervised numerous postgraduate students and contributed extensively to the field with multiple high-impact publications in reputable international journals. Some of his significant research publications include Synthesis and biological evaluations of 1,3,4-thiadiazole derivatives as dual acting enzyme inhibitors to target inflammation and diabetes, Carbothioamides as anticancer agents: synthesis, in-vitro activity, structure-activity relationship evaluations and molecular docking, Synthesis of (E)-3-(aryl)-1-phenylprop-2-en-1-one Chalcone Derivatives for Hyperglycemic Effect in Diabetes.

Profile: Google Scholar

Featured Publications

Li, S., Zhan, L., Zhao, W., Zhang, S., Ali, B., Fu, Z., Lau, T. K., Lu, X., Shi, M., Li, C. Z., … (2018). Revealing the effects of molecular packing on the performances of polymer solar cells based on A–D–C–D–A type non-fullerene acceptors. Journal of Materials Chemistry A, 6(25), 12132–12141.

Ali, F., Khan, K. M., Salar, U., Iqbal, S., Taha, M., Ismail, N. H., Perveen, S., … (2016). Dihydropyrimidones: As novel class of β-glucuronidase inhibitors. Bioorganic & Medicinal Chemistry, 24(16), 3624–3635.

Abbas, A., Ali, B., Khan, K. M., Iqbal, J., Rahman, S. U., Zaib, S., Perveen, S. (2019). Synthesis and in vitro urease inhibitory activity of benzohydrazide derivatives, in silico and kinetic studies. Bioorganic Chemistry, 82, 163–177.

Ali, B., Khan, K. M., Hussain, S., Hussain, S., Ashraf, M., Riaz, M., Wadood, A., … (2018). Synthetic nicotinic/isonicotinic thiosemicarbazides: In vitro urease inhibitory activities and molecular docking studies. Bioorganic Chemistry, 79, 34–45.

Naz, F., Latif, M., Salar, U., Khan, K. M., Al-Rashida, M., Ali, I., Ali, B., Taha, M., … (2020). 4-Oxycoumarinyl linked acetohydrazide Schiff bases as potent urease inhibitors. Bioorganic Chemistry, 105, 104365.

Salar, U., Khan, K. M., Taha, M., Ismail, N. H., Ali, B., Perveen, S., Ghufran, M., … (2017). Biology-oriented drug synthesis (BIODS): In vitro β-glucuronidase inhibitory and in silico studies on 2-(2-methyl-5-nitro-1H-imidazol-1-yl) ethyl aryl carboxylate derivatives. European Journal of Medicinal Chemistry, 125, 1289–1299.

Ali, M., Khan, K. M., Salar, U., Ashraf, M., Taha, M., Wadood, A., Hamid, S., Riaz, M., … (2018). Synthesis, in vitro α-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives. Molecular Diversity, 22(4), 841–861.

Wuting Lu | Drug Discovery and Development | Best Researcher Award

Dr. Wuting Lu | Drug Discovery and Development | Best Researcher Award

Dr. Wuting Lu at Jiangxi Academy of Sciences | China

Dr. Wuting Lu is a dedicated researcher specializing in immunotoxicology, neurobiology, and aquatic toxicology. With a strong academic background and diverse research experience, Dr. Lu has contributed significantly to understanding environmental toxicants and their effects on immunity and neurodevelopment using zebrafish models. He has participated in multiple National Natural Science Foundation of China projects, focusing on mechanisms of high-risk autism genes and their impact on the gut-immune-brain axis. His work has resulted in several high-impact journal publications, advancing knowledge in environmental safety, immunology, and neurobiology. Currently, he serves as Assistant Research Fellow at the Institute of Microbiology, Jiangxi Academy of Sciences.

Publication Profile 

Orcid

Education 

Dr. Wuting Lu completed his Ph.D. in Biology at Nanchang University, where his research explored immunotoxicity and neurodevelopmental effects of environmental pollutants. He earned his M.S. in Neurobiology, also from Nanchang University, focusing on molecular and cellular mechanisms in the nervous system. His academic journey began with a B.S. in Aquaculture at Dalian Ocean University, providing him with a strong foundation in aquatic biology and toxicology. This multidisciplinary training enabled him to integrate environmental science, immunology, and neuroscience into his research, developing expertise in both experimental techniques and advanced molecular analysis approaches for investigating complex biological interactions.

Experience 

Dr. Wuting Lu professional career includes roles in academic research and laboratory management. He currently serves as Assistant Research Fellow at the Institute of Microbiology, Jiangxi Academy of Sciences, where he investigates immunotoxicity and neurotoxicity mechanisms. Before this, he worked as a Laboratory Technician at Jinggangshan University, gaining hands-on experience in molecular biology, immunology, and laboratory safety management. He has actively participated in several National Natural Science Foundation of China projects, contributing to studies on autism gene regulation, microglial activation, and the gut-immune-brain axis. His multidisciplinary experience spans aquatic toxicology, neurobiology, immunology, and transcriptomic analysis, bridging fundamental research with environmental health concerns.

Awards and Honors 

Dr. Wuting Lu has received recognition for his research contributions through participation in multiple National Natural Science Foundation of China projects, including studies on the high-risk autism gene CHD8 and its effects on microglial activation and the gut-immune-brain axis. His publications in leading journals, such as Fish & Shellfish Immunology and Ecotoxicology and Environmental Safety, highlight his impactful work on immunotoxicity, neurotoxicity, and antioxidant mechanisms in aquatic organisms. While early in his independent research career, his achievements demonstrate excellence in experimental design, molecular analysis, and scientific communication, positioning him as a promising researcher in environmental health and neuroimmunology fields.

Research Focus 

Dr. Wuting Lu research focuses on immunotoxicity, neurotoxicity, and environmental safety, particularly investigating the effects of environmental toxicants on immune and nervous system development using zebrafish as a model organism. He explores molecular mechanisms underlying pollutant-induced oxidative stress, immune dysregulation, and neurodevelopmental impairments. Additionally, he studies the regulatory roles of genes, such as CHD8, in microglial activation and the gut-immune-brain axis, linking environmental exposures to autism spectrum disorders. His work integrates toxicology, transcriptomics, and neuroimmunology to elucidate pathways of toxicity, identify potential biomarkers, and provide insights into environmental risk assessment, contributing to public health and ecological sustainability research.

Publication Top Notes

Immunotoxicity and neurotoxicity induced by natural borneol and synthetic borneol in zebrafish (Danio rerio)

Immunotoxicity and transcriptome analysis of zebrafish embryos exposure to Nitazoxanide

Conclusion

Overall, Dr. Wuting Lu exhibits a strong research trajectory with impactful publications, interdisciplinary expertise, and contributions to nationally funded projects. His work in environmental toxicology, neurobiology, and molecular mechanisms aligns well with the objectives of the Best Researcher Award. With continued focus on independent project leadership and global collaboration, Dr. Lu has the potential not only to be a strong award candidate but also to emerge as a leading researcher in his field.

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Awatef Sassi | Drug Discovery and Development | Women Researcher Award

Dr. Awatef Sassi, Faculty of medicine of sousse, Tunisia

Dr. Awatef Sassi 🧬🔬 is a distinguished postdoctoral researcher at the Faculty of Medicine of Sousse, specializing in cardiovascular and metabolic research. She earned her Ph.D. in Biological Sciences (2018) from the Faculty of Science of Bizerte, following a Master’s in Vascular Diseases Biology (2011) and a Medical Biotechnology degree (2008). Dr. Sassi has contributed significantly to scientific advancements, securing a patent on anti-hypertensive properties of Rosmarinus officinalis and publishing in high-impact journals. She is actively involved in mentoring medical theses and conducting innovative research in biophysics and applied toxicology. 🌿📊

Publication Profile

Orcid

Education

Dr. Awatef Sassi is a distinguished scholar in biological sciences 🧬, biotechnology 🏥, and vascular diseases ❤️. With a Ph.D. in Biological Sciences 🎓, a Master’s in Vascular Disease Biology, and a Medical Biotechnology degree, she has demonstrated an unwavering commitment to scientific research 🔬. Her extensive expertise spans innovative biotechnological applications and advancements in vascular health, contributing significantly to the medical and scientific communities. Dr. Sassi’s dedication to excellence and groundbreaking research continues to shape the future of biotechnology and vascular medicine, making her a respected figure in the field 🌟.

Experience 

Dr. Awatef Sassi’s postdoctoral research at the Faculty of Medicine in Sousse 🏥 has focused on cardio-pulmonary interactions 💓💨 and biophysics ⚛️, making significant contributions to biomedical sciences. As a dedicated mentor, she has supervised multiple medical theses 📚, showcasing her leadership in academia. Her patented innovation 🏅 on the antihypertensive activity of Rosmarinus officinalis 🌿 (TN 2023/0143) highlights groundbreaking research with potential clinical impact in hypertension treatment 💊. Through her pioneering work, Dr. Sassi continues to advance medical science, bridging research and practical healthcare solutions for improved cardiovascular health ❤️.

Professional Development

Dr. Awatef Sassi is a dedicated educator and researcher 🎓🔬, with extensive experience as a lecturer in analytical chemistry ⚗️. Her involvement in postgraduate training 📚 has strengthened expertise in HPLC/UPLC 💉, mass spectrometry 🧪, and data analysis (SPSS) 📊. Through her teaching and mentorship, she equips students and researchers with essential analytical and computational skills, fostering scientific excellence. Dr. Sassi’s commitment to professional development ensures that future scientists gain hands-on experience in advanced laboratory techniques, making a lasting impact in biotechnology, pharmacology, and medical sciences 🏥🌿.

Research Focus

Dr. Awatef Sassi’s research primarily focuses on phytomedicine 🌿, clinical nutrition 🥗, cardiovascular health ❤️, and pharmaceutical sciences 💊. Her work explores the therapeutic potential of medicinal plants like Rosmarinus officinalis and Nitraria retusa for conditions such as hypertension, obesity, and lipid disorders. Additionally, she has contributed to cardiovascular interventions 🏥, dermatological formulations, and transfusion medicine 🩸. Her studies include randomized clinical trials, pilot studies, and formulation research, highlighting her interdisciplinary approach to natural product-based therapy and clinical pharmacology. Her work significantly impacts personalized medicine, preventive healthcare, and alternative treatment strategies.

Publication Top Notes

The Effect of Rosmarinus officinalis L Infusion Supplementation on Blood Pressure Among Healthy Volunteers and Grade 1 Hypertensive Patients

Antiobesity and Hypolipidemic Potential of Nitraria retusa Extract in Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Study

Exploring the Effects of Short-Term Daily Intake of Nitraria retusa Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults

Distal radial approach versus conventional radial approach: a comparative study of feasibility and safety

Formulation and evaluation of topical halofuginone gel using a novel <I>ex vivo</i> model

RHD genotyping and its implication in transfusion practice

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Shanthi Veerappapillai | Drug Discovery and Development | Best Researcher Award

Dr Shanthi Veerappapillai, Vellore Institute of Technology, India

Dr. Shanthi Veerappapillai is a distinguished Professor at VIT University, specializing in Bioinformatics and Computational Biology. With a Ph.D. from VIT, her research interests include computational protein analysis, drug resistance studies, and virtual screening, particularly focusing on infectious diseases like HIV and tuberculosis. She has led multiple funded research projects and published over 130 peer-reviewed articles. Dr. Veerappapillai has been recognized with awards like the Women Achiever Award for Sponsored Research Excellence (2020) and has supervised numerous Ph.D. graduates. Her dedication to education and research is also reflected in her active participation in conferences and professional societies. 👩‍🔬📚💻🌍

Publication Profile

Google Scholar

Education Qualification

Dr. Shanthi Veerappapillai holds a Ph.D. in Bioinformatics from VIT University, Tamil Nadu, India, and an M.Tech in Chemical Process and Design from SASTRA University, Tamil Nadu, India. She also earned a B.Tech in Chemical Engineering from EGS Pillai Engineering College, Bharathidasan University, Tamil Nadu, India. With a strong foundation in both chemical engineering and bioinformatics, Dr. Veerappapillai brings a multidisciplinary approach to her research and academic work. Her diverse academic background equips her with the expertise to bridge the gap between technology and biology, contributing to advancements in various scientific fields. 🧬⚙️🎓

Leadership in Research

Dr. Shanthi Veerappapillai is a dedicated scientist with extensive leadership experience as Principal Investigator (PI) in multiple prominent projects. Her research spans critical areas such as drug repurposing strategies and cancer research, showcasing her expertise in advancing both medical and computational biology. Through her work, she has contributed significantly to the development of innovative therapeutic approaches, emphasizing her commitment to enhancing healthcare and medical research. Her ability to lead and collaborate on large-scale projects underscores her impact in the field, making her a valuable asset in shaping the future of medical science and computational biology. 🧬🔬💊

Mentorship and Teaching

Dr. Shanthi Veerappapillai is a distinguished academic with vast experience in supervising successful Ph.D. candidates and teaching specialized subjects in biotechnology and bioinformatics. Her dedication to fostering academic development is evident in her role as a mentor to future researchers. With a passion for guiding students through advanced research topics, she has contributed significantly to shaping the next generation of experts in her field. Her work in biotechnology and bioinformatics continues to inspire students, encouraging innovation and critical thinking in these dynamic disciplines. 👩‍🔬📚🎓🔬👩‍💻

Community Engagement

Dr. Shanthi Veerappapillai is a dedicated academician who has made significant contributions to the scientific community through her active involvement in organizing conferences and workshops. As a member of various professional bodies, Dr. Veerappapillai continuously strengthens her presence in the academic world, sharing her expertise and collaborating with fellow researchers. Her commitment to advancing knowledge and fostering professional connections has had a lasting impact on her field. With a focus on promoting growth in the academic and scientific community, Dr. Veerappapillai’s efforts continue to inspire others. 🌍🧑‍🏫📚

Awards and Achievement

Dr. Shanthi Veerappapillai is a distinguished researcher with 131 peer-reviewed journal articles and an H-index of 14. She received the Best Chapter Award from BRSI-VIT for her exceptional contributions in 2023. She was honored with the Women Achiever Award for Sponsored Research Excellence in 2020 and has been a Research Fellow at INTI International University, Malaysia since June 2023. Dr. Veerappapillai’s academic journey includes producing 100% results in Chemical Engineering Thermodynamics courses and securing university ranks and prizes for academic excellence. She has also received several accolades, including a Best Poster Presentation Award at VIT University. 🏆📚👩‍🔬🌟

Research Focus

Dr. V. Shanthi’s research primarily focuses on molecular simulation, bioinformatics, and computational approaches to drug discovery. She has explored mechanisms of drug resistance, particularly in influenza virus neuraminidase, using molecular simulations to understand oseltamivir resistance. Her work also spans polypharmacology, investigating therapeutic agents for non-small cell lung cancer, and the identification of potential inhibitors for various viruses like H5N1. Additionally, she has contributed to bioprocess industry applications, drug repurposing, and plant-based therapeutic compounds. Her research aims at enhancing drug design, discovering novel therapeutic agents, and understanding the molecular interactions that govern drug efficacy. 🔬💊🦠💡

Publication Top Notes

Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach

Current progress and future perspectives of polypharmacology: From the view of non-small cell lung cancer

Bioactive Amento flavone isolated from Cassia fistula L. leaves exhibits therapeutic efficacy

Application of heat exchangers in bioprocess industry: a review

Multi-dimensional screening strategy for drug repurposing with statistical framework—a new road to influenza drug discovery

Identification of potential inhibitors of H5N1 influenza A virus neuraminidase by ligand-based virtual screening approach

Role of the cation-π interaction in therapeutic proteins: A comparative study with conventional stabilizing forces

 

 

 

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Ayaz Ahmed | Drug Discovery and Development | Best Researcher Award

Dr Ayaz Ahmed, ICCBS – University of Karachi, Pakistan

Dr. Ayaz Ahmed 🧬🔬 is a Principal Investigator and Assistant Professor at the Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD), ICCBS, University of Karachi, Pakistan. With a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China, and an M.Sc. in Microbiology from the University of Karachi, his research focuses on microbial profiling, anti-biofilm agents, and infectious disease models. Dr. Ahmed has supervised numerous postgraduate students and received multiple international awards, including recognition from the American Society for Microbiology and Bill & Melinda Gates Foundation. He also leads funded projects on combating antibiotic-resistant pathogens. 🌟

Publication Profile

google scholar

Qualifications

Dr. Ayaz Ahmed holds a Ph.D. in Biochemistry and Molecular Biology from Dalian Medical University, China (2012), and a Master’s in Microbiology from the University of Karachi, Pakistan (2006, First Division). 🧬🎓 His doctoral research focused on the “Microbial profiling of dental plaque/Biofilm from dental caries and periodontitis patients” and explored the effects of Lactobacillus species on S. mutans biofilm formation. 🦷🔬 With a strong academic foundation and research expertise in microbiology and molecular biology, Dr. Ayaz contributes significantly to the understanding of microbial interactions in dental health and disease. 🌟

Job Responsibilities

Dr. Ayaz Ahmed is a Principal Investigator at the Cell Biology Lab, where he oversees the Imaging Facility, maintaining high-end fluorescence and light microscopes. He supports students by assisting them in acquiring high-quality images for their theses and manuscripts. Dr. Ahmed also manages the National Animal Facility for Laboratory Animal Research and Care. He supervises routine animal house operations and collaborates with a veterinary doctor to maintain SPF rats, mice, and hamsters. He is responsible for establishing models for infectious diseases and memory deficits to evaluate the efficacy of natural compounds. Dr. Ahmed also conducts toxicological studies and trains students in ethical animal research practices. 🧬🔬🐁

Student Supervised

Dr. Ayaz Ahmed and his team of dedicated researchers have made significant strides in their exploration of innovative therapeutic strategies. Among the Ph.D. candidates, Zulfiqar Ahmed’s research on controlling salmonellosis through probiotics in poultry, Binte Zehra’s study on modulating the metastatic potential of NSCLC, and Jazib Shafiq’s investigation into gut dysbiosis and anxiety have all been awarded. Additionally, Afshan Shams, Yamina Usmani, and Shariqa Khuwaja are examining the potential of natural and synthetic compounds in combating oral cancer and other diseases. Several M. Phil. students are also contributing to research on antimicrobial resistance and cancer therapies. 🧪🔬🧫

Honors and Awards

Dr. Ayaz Ahmed has earned numerous accolades throughout his distinguished career. In 2024, he received the Award for Collaborative Scientific Achievement from the Institute of Food Science and Technology, Chinese Academy of Agriculture Science, Beijing. He also became an International Federation for Biosafety Association (IFBA) Certified Biological Waste Management Professional and Bio-risk Management Professional in 2023. Dr. Ahmed was selected as a Mentor for the ASM Future Leaders Mentoring Fellowship Program in 2023 and was awarded the Health Security Partner Grant by the Bill & Melinda Gates Foundation in 2021. He has also earned prestigious travel awards and fellowships, including the American Society for Microbiology ID Fellowship and the Science and Technology Talent Award. 🏅🌍🦠

Completed Projects

Dr. Ayaz Ahmed has led multiple impactful research projects focused on combating multidrug-resistant microorganisms and improving public health. His research on the effect of synthetic and natural compounds on biofilm formation was funded by the Higher Education Commission of Pakistan (HEC) under project # HEC No: PD-IPFP/HRD/HEC/ 2013/1182. He also contributed to projects such as Personal Protective Equipment for Sindh Poultry Vaccine Center (funded by CRDF Global, USA), and oral pathogens related to dental caries (funded by ICCBS). Notably, his work on antimicrobial-resistant water contaminants, funded by the U.S.-Pakistan Centers for Advanced Studies in Water, aims to improve water quality. He further advanced research on antimicrobial and antibiofilm agents targeting Acinetobacter baumannii and Klebsiella pneumonia with funding from HEC. 💧🔬🦠

Professional Experience

Dr. Ayaz Ahmed has had a distinguished career in academia and research. Since June 2017, he has been serving as an Assistant Professor at the International Center for Chemical and Biological Sciences, University of Karachi. Prior to this, he worked as a Senior Research Officer at the same institution from November 2013 to June 2017. Dr. Ahmed also pursued Post-Doctoral training in Behavioral Sciences at Hunan Drug Safety Evaluation in Changsha, China, from January 2016 to February 2017. His earlier roles include Assistant Professor on Interim Placement, Research Officer in Avian Influenza Vaccine Production, and a research intern in the National Internship Program. 🧪📚

Professional Membership

Dr. Ayaz Ahmed is an active member of several prestigious professional organizations, contributing significantly to the fields of microbiology and infectious diseases. His memberships include the American Society for Microbiology (ASM) 🦠, the Pakistan Biological Safety Association (PBSA) 🧫, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 🌍. Additionally, he is a member of the American Association of Cancer Research (AACR) 🎗️ and the Medical Microbiology & Infectious Disease Society of Pakistan (MMIDSP) 🇵🇰. These memberships reflect his commitment to advancing research and innovation in microbiology, infectious diseases, and cancer research.

Research Focus

Dr. Ayaz Ayaz Ahmed research focus primarily revolves around microbiology, particularly in the fields of gut microbiota analysis, antimicrobial resistance, and biofilm formation. His studies often investigate the interactions between microorganisms and the human or animal host, such as comparing gut microbe profiles between healthy individuals and those with conditions like hyperthyroidism and liver cirrhosis. Additionally, Dr. Ahmed explores innovative therapeutic approaches, including the development of antimicrobial agents, such as nanoparticles conjugated with antibiotics to combat biofilm-forming pathogens like Klebsiella pneumoniae and Staphylococcus aureus. His work has significant implications for medical microbiology and the treatment of infectious diseases. 🦠🔬

Publication Top Notes

Gut microbe analysis between hyperthyroid and healthy individuals

Phylogenetic and biological characterization of Newcastle disease virus isolates from Pakistan

Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae

Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals

Rifampicin conjugated silver nanoparticles: a new arena for development of antibiofilm potential against methicillin resistant Staphylococcus aureus and Klebsiella pneumoniae

Effect of Lactobacillus species on Streptococcus mutans biofilm formation.

Comparison of oral microbiota in orthodontic patients and healthy individuals

Synthesis and Chemosensing of Nitrofurazone using Olive oil based Silver Nanoparticles (O-AgNPs)

Isolation of dihydrobenzofuran derivatives from ethnomedicinal species Polygonum barbatum as anticancer compounds

Prof. Maysoon Al-Haideri| Drug Discovery |Best Researcher Award

Prof. Maysoon Al-Haideri|Drug Discovery|Best Researcher Award

Prof. Maysoon Al-Haideri at University oh Kurdistan Hewlêr,Iraq

PROFILE  

scopus 

 

Early Academic Pursuits 🎓

Dr. Al-Haideri began her educational journey at Baghdad University, where she completed her B.Sc. in Pharmacy in 1973. She demonstrated early promise and a strong interest in clinical analysis, leading her to pursue an Advanced Diploma in Clinical Analysis from Baghdad University between 1977 and 1979. Her academic curiosity and pursuit of excellence took her to the United States, where she attended Columbia University in the City of New York, earning a Master of Arts (M.A.) in 1983, followed by an M.Phil. in Pathology in 1985. Her dedication and passion culminated in a Ph.D. in Pathology from Columbia University in 1987, marking the beginning of an illustrious career in clinical research and academia.

Professional Endeavors 🩺

Dr. Al-Haideri’s professional career began in Iraq, where she gained practical experience and took on leadership roles in several medical institutions. She completed a traineeship in Clinical Hematology, Clinical Biochemistry, Medical Microbiology, Parasitology, and Infectious Diseases at the Ministry of Health in Baghdad from 1974 to 1975. Following this, she served as the Director of the Clinical Laboratory at Abo-Alkhaseab Hospital in Basrah (1975-1976) and Chief of the Clinical Biochemistry and Hematology Divisions at Al-Khadmia Teaching Hospital in Baghdad (1976-1981). During this time, she was also responsible for student supervision and training, highlighting her commitment to fostering the next generation of healthcare professionals.

From 1981 to 1982, Dr. Al-Haideri took on a national role as the Director of Quality Control and Standardization for all public clinical laboratories in Iraq, ensuring the consistent application of best practices in clinical analysis. Her leadership and expertise were further recognized when she undertook a traineeship in infertility at the Ministry of Health in Baghdad in 1982, signaling her growing influence in medical diagnostics and reproductive health.

In the United States, Dr. Al-Haideri continued her impressive trajectory, completing a postdoctoral fellowship at North Shore University Hospital, Manhasset, New York (1987-1988), followed by research positions at Long Island Jewish Medical Center (1988-1990) and Albert Einstein College of Medicine, Bronx, New York (1989-1991). During this time, she held the title of Instructor of Immunology, Rheumatology, and Allergy. Dr. Al-Haideri’s academic and research career reached new heights when she joined Columbia University’s College of Physicians and Surgeons, where she worked as an NIH Postdoctoral Research Trainee (1991-1994), eventually becoming an Associate Research Scientist and Assistant Professor (1994-2004).

Contributions and Research Focus 🔬

Dr. Al-Haideri’s research has primarily focused on clinical pathology, immunology, rheumatology, and allergy. Her work has been instrumental in enhancing the understanding of immunological responses in various pathological conditions. She has been actively involved in numerous research projects, often collaborating with leading medical institutions in both the U.S. and Iraq.

Her role as Director of Quality Control and Standardization in Iraq’s Ministry of Health laid the groundwork for the development of national policies aimed at ensuring the accuracy and reliability of clinical laboratory diagnostics across the country. In the U.S., her work at prestigious institutions like Columbia University and Albert Einstein College of Medicine helped advance the field of immunology, particularly in relation to autoimmune diseases.

Accolades and Recognition 🏆

Dr. Al-Haideri’s work has been widely recognized through various awards and honors. She received NIH Grant Awards from 1991 to 1994, which supported her groundbreaking research in immunology and pathology. Her academic excellence was also acknowledged at Columbia University, where she was awarded Graduate Research Assistantships.

Her commitment to medical education and healthcare development in Iraq earned her numerous accolades, including being named Employee of the Year at Hawler Medical University in Erbil, Kurdistan in 2012. Additionally, she received letters of appreciation from the Minister of Higher Education and Scientific Research in the Kurdistan region, as well as from the President of Hawler Medical University and several deans of colleges at the university for her contributions to education and healthcare.

Impact and Influence 🌍

Dr. Al-Haideri has had a profound impact on medical education and healthcare both in Iraq and abroad. As a leader in various institutions, she has played a critical role in shaping the medical education system in the Kurdistan Region of Iraq. Her tenure as Dean of the College of Health Sciences at Hawler Medical University (2014-2018) and Director of Quality Assurance (2010-2015) helped set new standards for academic excellence and institutional leadership in the region.

Her influence extends beyond academia. Dr. Al-Haideri has been an active member of numerous professional societies, including the American Society for Biochemistry and Molecular Biology and the American Heart Association, further cementing her status as a respected expert in her field. Her involvement in international organizations, such as the International Institute of Education in New York, reflects her commitment to global collaboration and knowledge exchange.

Legacy and Future Contributions 🔮

Dr. Maysoon Tahir Al-Haideri’s legacy is one of dedication to advancing medical knowledge, improving healthcare systems, and fostering academic excellence. Her work has had a lasting impact on the clinical and academic landscapes in Iraq, particularly in the Kurdistan region, where she has influenced generations of healthcare professionals through her leadership roles at Hawler Medical University and Cihan University-Erbil.

As she continues her work as the Director of the Pharmacy Program at the University of Kurdistan Hewler, Dr. Al-Haideri remains committed to mentoring students and contributing to the development of the healthcare sector in the region. Her achievements serve as an inspiration to future generations of scientists, educators, and healthcare professionals, ensuring her legacy will endure for years to come.

🎓Publication 

Silymarin suppresses proliferation and PD-L1 expression in colorectal cancer cells and increases inflammatory CD8+ cells in tumor-bearing mice

  • Authors   :Al-Haideri, M.
  • Journal    :Clinics and Research in Hepatology and Gastroenterology
  • Year         :2024

Functional and financial analysis of an inclined step solar desalination using phase change nanomaterials

  • Authors   : Mahal, A., Al-Haideri, M., Alkhouri, A., Obaidullah, A.J., Duan, M.
  • Journal    :Water Science and Technology
  • Year         :2024

Tuning the optoelectronic properties of selenophene-diketopyrrolopyrrole-based non-fullerene acceptor to obtain efficient organic solar cells through end-capped modification

  • Authors   :Ijaz, R., Waqas, M., Mahal, A., Alatawi, N.S., Aloui, Z.
  • Journal    :Journal of Molecular Graphics and Modelling,
  • Year         :2024

Rational designing of phenothiazine dioxide based hole transporting materials for efficient perovskite solar cells

  • Authors   : Hanan, M., Umair, Mahal, A., Farooq, Z., Mahr, M.S.
  • Journal    : Solar Energy,
  • Year         :2024

Linking the increasing epidemiology of scrub typhus transmission in India and South Asia: are the varying environment and the reservoir animals the factors behind?

  • Authors   : Mohapatra, R.K., Al-Haideri, M., Mishra, S., Mohanty, A., Sah, R.
  • Journal    :Frontiers in Tropical Diseases,
  • Year         :2024

Dr. Rajendra Rohokale|Drug Discovery and Development| Best Researcher Award

Dr. Rajendra Rohokale| Drug Discovery and Development ,Best Researcher Award

Dr. Rajendra Rohokale at university of florida,United States

PROFILE  

Orcid

🎓Early Academic Pursuits :

Dr. Rajendra Shankarrao Rohokale embarked on his academic journey with a strong foundation in the sciences, earning his Bachelor of Science in Chemistry from New Arts, Science, and Commerce College, Ahmednagar, affiliated with Savitribai Phule Pune University, Pune, India. His academic pursuit continued with a Master of Science in Organic Chemistry from the same university, where he honed his skills in synthetic organic chemistry, laying the groundwork for his future research endeavors.

During his postgraduate studies, Dr. Rohokale demonstrated a profound interest in organic chemistry, particularly in the areas of synthetic carbohydrate chemistry and glycoscience. His early academic years were marked by a commitment to exploring the complexities of organic compounds, setting the stage for his later achievements in the field.

💼Professional Endeavors :

Dr. Rohokale’s professional journey is characterized by significant contributions to the field of synthetic organic chemistry, with a focus on carbohydrate chemistry, glycoscience, and photoredox catalysis. After completing his Ph.D. in Organic Chemistry from the Department of Chemistry, Savitribai Phule Pune University, he joined the University of Florida as a Research Assistant Professor. Under the mentorship of Prof. Zhongwu Guo, a prominent figure in carbohydrate chemistry, Dr. Rohokale’s work primarily involved the synthesis of complex carbohydrates and their conjugates for therapeutic applications.

Before his tenure at the University of Florida, Dr. Rohokale held a prestigious SERB National Post-doctoral Fellowship at the National Chemical Laboratory, Pune, where he worked under the guidance of Dr. C. V. Ramana. His research during this period focused on the applications of iridium-catalyzed reactions and photoredox catalysis in organic chemistry, contributing to the development of new methodologies in the field.

Dr. Rohokale’s professional experience also includes an international collaboration during the Indigo Program-2012, where he worked on visible light photoredox-catalysis with Prof. Burkhard Koenig at the University of Regensburg, Germany. This collaboration further enriched his research profile, leading to innovative contributions in organic synthesis.

🔬Contributions and Research Focus :

Dr. Rohokale has made significant contributions to the fields of synthetic organic chemistry, carbohydrate chemistry, and photoredox catalysis. His research primarily focuses on developing practical and efficient methods for the chemical and chemoenzymatic synthesis of complex oligosaccharides and glycoconjugates. These include glycoproteins and glycolipids, which are applied to studying related biological and medical problems, such as the functions of glycans and their relationships with diseases.

One of Dr. Rohokale’s notable research contributions is in the area of glycolipids synthesis. His work on glycosylated liposomes for targeted drug delivery and vaccination has potential applications in diagnosing and treating human diseases, including cancer and bacterial infections. His research also extends to the synthesis of biologically relevant molecules, such as GSLs, and their use as probes to explore disease mechanisms.

🏅Accolades and Recognition :

Dr. Rohokale’s academic and research excellence has been recognized through various awards and honors. He was selected for the prestigious SERB National Post-doctoral Fellowship in 2017, acknowledging his potential to contribute to scientific research in India. His selection as a Post-doctoral Fellow at the University of Florida in 2019 further underscores his expertise in carbohydrate chemistry and organic synthesis.

Additionally, Dr. Rohokale has been an active peer reviewer for several high-impact journals, including Chemical Communication and Organic Chemistry Frontiers, published by the Royal Society of Chemistry, and The Journal of Carbohydrate Chemistry, published by the American Chemical Society. His role as a reviewer highlights his standing in the scientific community and his commitment to advancing research in his field.

🌍Impact and Influence :

Dr. Rohokale’s research has had a profound impact on the field of synthetic organic chemistry, particularly in the areas of carbohydrate chemistry and photoredox catalysis. His work on the synthesis of complex carbohydrates and glycoconjugates has implications for medical science, particularly in understanding the role of glycans in diseases and developing new diagnostic tools and therapeutic approaches.

His innovative methodologies in organic synthesis have influenced researchers globally, contributing to the development of new strategies for synthesizing biologically relevant molecules. His collaboration with international institutions, including his work in Germany and the USA, has further extended his influence, making him a respected figure in his field.

🌟Legacy and Future Contributions :

As Dr. Rohokale continues his research at the University of Florida, his legacy in synthetic organic chemistry and carbohydrate research is expected to grow. His contributions to the development of new synthetic methods and their applications in medical science position him as a leading researcher with the potential to make groundbreaking discoveries in the future

🎓Publication 

Diastereoselective 1,3-dipolar intramolecular nitrone olefin cycloaddition (INOC) reaction of a sugar-derived allyl alcohol: Synthesis of functionalized aminocyclopentitols

  • Authors   :Rajendra Rohokale
  • Journal    :
    Carbohydrate Research
  • Year         :2024

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

  • Authors :Sayan Kundu; Rajendra Rohokale; Chuwei Lin; Sixue Chen; Shayak Biswas; Zhongwu Guo
    • Journal   :
      Journal of Lipid Research
    • Year       : 2024

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

  •  Authors  :Rajendra Rohokale; Jiatong Guo; Zhongwu Guo
  • Journal    :
    Journal of Medicinal Chemistry

    Year         :  2024

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

  • Authors  :: Rajendra Rohokale; Zhongwu Guo
  • Journal   :
    ACS Infectious Diseases
  • Year        :   2023

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

  • Authors  :Gao, T.; Lott, A.A.; Huang, F.; Rohokale, R.; Li, Q.; Olivos, H.J.; Chen, S.; Guo, Z.
  • Journal   :
    Analyst
  • Year        :  2022